202 related articles for article (PubMed ID: 37575320)
1. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors.
Yan X; Wang J; Mao J; Wang Y; Wang X; Yang M; Qiao H
Front Nutr; 2023; 10():1213255. PubMed ID: 37575320
[TBL] [Abstract][Full Text] [Related]
2. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis.
Liu C; Guo H; Mao H; Tong J; Yang M; Yan X
Front Oncol; 2022; 12():753234. PubMed ID: 35280736
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Xia H; Zhang W; Zheng Q; Zhang Y; Mu X; Wei C; Wang X; Liu Y
Heliyon; 2023 Aug; 9(8):e17400. PubMed ID: 37520982
[TBL] [Abstract][Full Text] [Related]
4. Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.
Xia H; Zhang W; Zhang Y; Shang X; Liu Y; Wang X
Front Oncol; 2022; 12():978069. PubMed ID: 36330494
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment "prognostic nutritional index" as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis.
Shao Y; Cao W; Gao X; Tang M; Zhu D; Liu W
Medicine (Baltimore); 2022 Oct; 101(43):e31113. PubMed ID: 36316884
[TBL] [Abstract][Full Text] [Related]
6. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
Front Oncol; 2022; 12():962173. PubMed ID: 36059629
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysis.
Li P; Lai Y; Tian L; Zhou Q
Cancer Med; 2022 Aug; 11(16):3048-3056. PubMed ID: 35297197
[TBL] [Abstract][Full Text] [Related]
10. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
[TBL] [Abstract][Full Text] [Related]
11. Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
Oku Y; Toyokawa G; Wakasu S; Kinoshita F; Takamori S; Watanabe K; Haratake N; Nagano T; Kosai K; Takada K; Fujimoto A; Higashijima K; Shiraishi Y; Tanaka K; Takeoka H; Okamoto M; Yamashita T; Shimokawa M; Shoji F; Yamazaki K; Okamoto T; Seto T; Ueda H; Takeo S; Nakashima N; Okamoto I; Takenaka T; Yoshizumi T
Cancer Med; 2023 Jul; 12(13):14327-14336. PubMed ID: 37211905
[TBL] [Abstract][Full Text] [Related]
12. Novel evidence for the prognostic impact of β-blockers in solid cancer patients receiving immune checkpoint inhibitors.
Yan X; Liu P; Li D; Hu R; Tao M; Zhu S; Wu W; Yang M; Qu X
Int Immunopharmacol; 2022 Dec; 113(Pt A):109383. PubMed ID: 36330916
[TBL] [Abstract][Full Text] [Related]
13. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.
Sun H; Chen L; Huang R; Pan H; Zuo Y; Zhao R; Xue Y; Song H
Front Nutr; 2022; 9():1038118. PubMed ID: 36438745
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study.
Wu M; Zhu Y; Chen X; Wang X; Lin X; Yan X; Mo P; Ye Y; Zeng Y; Yang Y; Fu Z
J Gastrointest Oncol; 2023 Feb; 14(1):54-63. PubMed ID: 36915449
[TBL] [Abstract][Full Text] [Related]
15. Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors.
Wang J; Guo H; Yang J; Mao J; Wang Y; Yan X; Guo H
Front Oncol; 2024; 14():1339729. PubMed ID: 38390262
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of Pretreatment Prognostic Nutritional Index in Advanced Lung Cancer Patients Receiving First-Line Immunotherapy: A Meta-Analysis.
Yang J; Li H; Li L; Lv J
Cureus; 2024 Jan; 16(1):e52720. PubMed ID: 38384634
[TBL] [Abstract][Full Text] [Related]
17. Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis.
Sun Q; Sun H; Wu N; Hu Y; Zhang F; Cong X
Front Oncol; 2022; 12():976224. PubMed ID: 36185176
[TBL] [Abstract][Full Text] [Related]
18. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
Chen N; Yu Y; Shen W; Xu X; Fan Y
Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
[TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors.
Chen X; Li Z; Zhou J; Wei Q; Wang X; Jiang R
PeerJ; 2022; 10():e14566. PubMed ID: 36540802
[TBL] [Abstract][Full Text] [Related]
20. Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy.
Fan R; Chen Y; Xu G; Pan W; Lv Y; Zhang Z
Front Oncol; 2023; 13():996312. PubMed ID: 37077828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
